Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes by Hossein Ashraf, Sezaneh Haghpanah, Mohammad Hossein Nowroozzadeh

Subjects: Get full text

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG? by S. V. Orlov, N. L. Shimanovskii, S. N. Fogt

Subjects: “…bevacizumab…”
Get full text

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy by Tian He, Bin Xu, Lu-Na Wang, Zi-Yi Wang, Huan-Chen Shi, Cheng-Jie Zhong, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Bo Hu, Cheng Huang

Subjects: Get full text

SUCCESSFUL REGISTRATION OF DOMESTIC BIOANALOGUE OF BEVACIZUMAB – NEW OPPORTUNITIES FOR EFFECTIVE TREA TMENT OF PATIENTS WITH NON-SQUAMOUS CELL NON-SMALL CELL LUNG CANCER by S. V. Orlov, S. N. Fogt, M. S. Shustova

Subjects: “…bevacizumab…”
Get full text

Comparison of reactivation between ranibizumab and bevacizumab in aggressive retinopathy of prematurity: A retrospective case series by Anil Babanrao Gangwe, Chibuzo B Ekumankama, Abhishek Singh, Swapnil Madhukar Parchand, Deepshikha Agrawal, Raj Vardhan Azad

Subjects: Get full text

Prognostics optical coherence tomography biomarker in macular oedema secondary to retinal vein occlusion by Andrea R. Silitonga, Hanna T.H. Silitonga, Rova Virgana, Iwan Sovani, Arief Kartasasmita, Erwin Iskandar, Grimaldi Ihsan, Made Indra

Subjects: Get full text

Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report by Song Xue, Jiaqi Chen, Yuzhu Shi, Lina Zhang, Man Chen, Huipeng Sun, Xingyu Cao, Fang Wu

Subjects: Get full text

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study by Zubeyir Yozgat, Mehmed Ugur Isik, Mehmet Cem Sabaner

Subjects: Get full text

PHARMACOECONOMICAL RESEARCH OF THE USE OF SORAFENIB IN MALIGNANT TUMORS by M. Y. Frolov, N. A. Avksentjev, I. G. Rusakov, E. V. Derkach

Subjects: Get full text